KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 22.42%.

  • Dynavax Technologies' EBITDA Margin rose 99200.0% to 22.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16%, marking a year-over-year increase of 73700.0%. This contributed to the annual value of 1.49% for FY2024, which is 144500.0% up from last year.
  • Per Dynavax Technologies' latest filing, its EBITDA Margin stood at 22.42% for Q3 2025, which was up 99200.0% from 15.12% recorded in Q2 2025.
  • Dynavax Technologies' 5-year EBITDA Margin high stood at 50.0% for Q2 2022, and its period low was 64.46% during Q1 2023.
  • Its 5-year average for EBITDA Margin is 8.57%, with a median of 14.84% in 2021.
  • Per our database at Business Quant, Dynavax Technologies' EBITDA Margin surged by 8921600bps in 2021 and then tumbled by -914500bps in 2023.
  • Quarter analysis of 5 years shows Dynavax Technologies' EBITDA Margin stood at 41.38% in 2021, then decreased by -17bps to 34.22% in 2022, then plummeted by -145bps to 15.27% in 2023, then surged by 85bps to 2.27% in 2024, then skyrocketed by 1090bps to 22.42% in 2025.
  • Its last three reported values are 22.42% in Q3 2025, 15.12% for Q2 2025, and 34.67% during Q1 2025.